Investing before the inflection

Investing at the frontier of human intelligence.

Forepont Capital Partners invests exclusively at the convergence of neuroscience and artificial intelligence, backing the companies defining the future of Brain AI and Brain-Computer Interfaces.

Explore Our Thesis

Scroll to explore

Why Forepont

Conviction before consensus.

Markets reward consensus. Venture capital rewards conviction.

Scientific revolutions rarely announce themselves.

They emerge years before financial markets recognize their significance.

Since 2017, we have invested where scientific conviction becomes tomorrow’s market leadership.

Forepont invests when scientific evidence validates what financial markets have yet to recognize. Our investment philosophy combines scientific expertise, disciplined conviction and a long-term perspective.

Scientific Expertise

Conviction Since 2017

Early Identification

Global Network

The next computing platform

Every computing revolution begins with a new interface.

Keyboard → Mouse → Touch → Voice → Brain AI

The keyboard transformed computing. The touchscreen redefined mobility. Brain AI is the next computing platform — a fundamental shift in how humans interact with intelligent systems.

From Brain-Computer Interfaces and neurotechnology to biologically inspired AI architectures that improve performance and efficiency while unlocking new capabilities. Forepont invests before these transformations become consensus.

Applications

The impact of Brain AI extends far beyond healthcare.

Explore Our Thesis

Restoring lost function through intelligent neural technologies.

Healthcare

Enabling seamless human-machine collaboration.

Robotics

Enhancing protection through intelligent cognitive systems.

Security

Supporting next-generation defense technologies.

Defense

Improving safety, productivity and decision-making.

Industry

Expanding human capabilities through Brain AI.

Cognitive Performance

1 | 6

Brain AI Flywheel

A self-reinforcing cycle of data, intelligence and value.

Brain Data → AI Applications → Proprietary Data → Interfaces → Brain Data

This cycle compounds defensibility and drives long-term value.

Explore Our Thesis

Our portfolio companies have been featured in

Bloomberg
Forbes
WIRED
Business Insider
Fierce Biotech

Portfolio highlights

Proof of conviction.

Explore the Portfolio

Since 2017

Exclusive Brain AI & BCI investment strategy

2 of 3

Global Brain AI leaders in our portfolio

*According to Forepont’s Brain AI market analysis, November 2025.

$181.5B

Projected global Brain-Computer Interface market by 2033

Source: Renub Research, 2024.

Synchron — Series D · $200M. Founded by Tom Oxley. Developing minimally invasive Brain-Computer Interfaces designed to restore independence for people living with paralysis.

Precision Neuroscience — Series C · $102M. Founded by Ben Rapoport. Building scalable neural interfaces for the future of human-machine interaction. Forepont holds a board seat.

International footprint

Connecting the world’s leading Brain AI ecosystems.

Our Network

Exceptional investing begins with exceptional expertise.

Managing Partner — New York

Eric M. Attias

Founder & Managing Partner

Managing Partner — Palo Alto

Konstantinos Alataris, PhD

Partner — New York

Doug Siekierski

Partner — Paris

Philippe Louisadat

Partner — London

Frederic Batoua

Scientific Advisory Board

Michel Vounatsos

Former CEO, Biogen

Scientific Advisory Board

Doug Weber

Carnegie Mellon University

Scientific Advisory Board

David Putrino

Mount Sinai

Scientific Advisory Board

Per Wold-Olsen

Former Merck & Co. executive; board member, Gilead Sciences and Novo Holdings

Team

Start a conversation

The future belongs to those investing before consensus.

We welcome conversations with institutional investors seeking differentiated exposure to one of the most significant technology opportunities of the coming decades.